We found a significant effect of ERRγ expression on OS of patients with serous ovarian cancer (HR 1.846; 95% CI 1.097–3.108, p = 0.021) making it an independent prognostic marker for OS in this subgroup of patients (Table 5). Here, ESRRG is linked to ovarian serous adenocarcinoma.